Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This study primarily introduces the application of liver metabolomics in investigating the effectiveness of Shi-Liu-Bu-Xue Syrup in treating anemia.

Abstract

As a well-known Uyghur medicine, Shi-Liu-Bu-Xue Syrup (SLBXS) has been widely used to treat anemia in China for over 20 years. However, the underlying mechanisms of its effectiveness in treating anemia remain unclear. In this study, liver metabolomics was primarily employed to determine the potential regulatory mechanisms of SLBXS in treating anemia. Liver metabolomics profiling was conducted to characterize the mechanism of action of SLBXS in an acetylphenylhydrazine-induced mouse model of anemia. SLBXS was shown to decrease liver index, white blood cell count, and platelet count, while increasing red blood cell count, hemoglobin, and hematocrit levels. Core targets were selected for verification using Western blotting. SLBXS demonstrated a significant therapeutic effect on anemia primarily by regulating galactose metabolism and the HIF-1 signaling pathway, as indicated by the downregulation of HIF-1α, NOS3, VEGFA, and GLA proteins in the liver tissues of anemic mice. This study clarifies the potential regulatory mechanisms of hepatic metabolism by SLBXS administration in treating anemia.

Introduction

Anemia is a pressing and prevalent global health issue, affecting 25% of the world's population and people of all ages, particularly adolescents and pregnant women1,2,3. It is associated with an increased risk of preterm labor and maternal mortality and can lead to physical developmental disorders and impaired cardiovascular performance4. This condition may also negatively impact the health status of adolescents, resulting in infections and heart failure5. Current treatments primarily include blood tran....

Protocol

All experimental procedures were approved by the Laboratory Animal Ethics Committee of the Hubei University of Chinese Medicine (HBUCMS201912015). Male C57BL/6 mice (weight 20-22 g) were housed in a specific pathogen-free room with a relative humidity of 50%-60% and a temperature of 22 °C ± 2 °C, subjected to a 12 h light/12 h dark cycle, and provided with free access to food and water. Before the experiment began, all mice were allowed one week to acclimate to the environment. Mice were randomly assigned .......

Representative Results

To confirm the successful establishment of the mouse model of anemia and analyze the effect of SLBXS on anemia, the liver index and hematological parameters were first investigated. Figure 1 illustrates that the model group exhibited a significant decrease (P < 0.01) in red blood cell count (RBC), hemoglobin (HGB), and hematocrit (HCT) compared to the control group. Conversely, the liver index, white blood cell count (WBC), and platelet count (PLT) in the model group were notabl.......

Discussion

Anemia is a common condition affecting many people worldwide, particularly in developing countries1. In China, patients frequently use traditional Chinese medicine, including Uyghur medicine, to alleviate the signs and symptoms of anemia. SLBXS is a Uyghur medicine that has been used in clinical practice for many years; however, its exact mechanism of action against anemia remains poorly understood13. In this study, a mouse model of acetylphenylhydrazine (APH)-induced anemi.......

Acknowledgements

This work was supported by the Special Training Plan for Minority Science and Technology Talents, Natural Science Foundation of Xinjiang Uyghur Autonomous Region (2020D03021), the Funds for Key Program for Traditional Chinese Medicine of Hubei University of Chinese Medicine (2022ZZXZ004), and Tianshan Innovation Team Program (2020D14030).

....

Materials

NameCompanyCatalog NumberComments
AcetylphenylhydrazineShanghai Aladdin Biochemical Technology Co., Ltd.C13979660
Automatic chemiluminescence imaging analysis systemShanghai Tanon Life Science Co., Ltd.Tanon-5200
Bicinchoninic acid assay kitThermoFisher ScientificQPBCA-1KT
Capillary columnAgilent J&W Scientific, Agilent Technologies, Inc.DB-5MS
Cell lysis buffer for Western and IPBeyotime BiotechnologyP0013
ChlorotrimethylsilaneShanghai Aladdin Biochemical Technology Co., Ltd.C104814
Electronic balanceMettler-Toledo International Inc.ME203E
Electronic scaleMettler-Toledo International Inc.LE104E
Fu-Fang-E-Jiao SyrupDong E E Jiao Co., Ltd.214020031
Fully automatic hemocyte analyzerShenzhen Mindray Animal Care Technology Co., Ltd.IDEXX ProCyte Dx
GC-MS systemAgilent Technologies, Inc.7890B-5977B 
GLA primary antibodyBioworld TechnologyBS77041
Glass homogenizerShanghai Lei Gu Instruments Co., Ltd.B-013001
Glass rod Shanghai Lei Gu Instruments Co., Ltd.B-003904
GraphPad Prism software GraphPad, La JollaVersion 9.0
Heparinized sample tubesChangde BKMAM Biotechnology Co., Ltd.B-ACT1P5
HIF-1α primary antibodyBioworld TechnologyBS3514
HMDB databasehttp://www.hmdb.ca/
IsofluraneHebei Jindafu Pharmaceutical Co., Ltd.20231202
Male C57BL/6 miceLiaoning Changsheng Biotechnology Co., Ltd.No. SCXK [Liao] 2015-0001
MassHunterAgilent Technologies, Inc.B.08.00
MetaboAnalyst 5.0https://www.metaboanalyst.ca/
Methoxyamine hydrochlorideShanghai Aladdin Biochemical Technology Co., Ltd.E1818113
n-hexaneShanghai Aladdin Biochemical Technology Co., Ltd.C14878803
NIST databasehttp://webbook.nist.gov/chemistry/
NOS3 primary antibodyBioworld TechnologyBS3625
PyridineShanghai Aladdin Biochemical Technology Co., Ltd.C13026996
SalineBIOSHARP LIFE SCIENCES2308262009
Shi-Liu-Bu-Xue SyrupXinjiang Uygur Pharmaceutical Co., Ltd.211277
Surgical manipulation plateDIXSGZK-JPB-A
VEGFA primary antibodyBioworld TechnologyAP0742
β-actinABclonal (Shanghai) Trading Co., Ltd.AC026

References

  1. Munoz, M., Gomez-Ramirez, S., Bhandari, S. The safety of available treatment options for iron-deficiency anemia. Expert Opin Drug Saf. 17 (2), 149-159 (2018).
  2. Soliman, A. T., De Sanctis, V., Yassin, M., Wagdy, M., Soliman, N. Chronic anemia and thy....

Explore More Articles

Medicine

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved